Cerus Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $3.4900
- Today's High:
- $3.7100
- Open Price:
- $3.6700
- 52W Low:
- $3.27
- 52W High:
- $8.06
- Prev. Close:
- $3.6900
- Volume:
- 2069980
Company Statistics
- Market Cap.:
- $0.618 billion
- Book Value:
- 0.428
- Revenue TTM:
- $0.154 billion
- Operating Margin TTM:
- -22.5%
- Gross Profit TTM:
- $0.067 billion
- Gross Profit TTM:
- $0.067 billion
- Profit Margin:
- -27.3%
- Return on Assets TTM:
- -9.89%
- Return on Equity TTM:
- -52.5%
Company Profile
Cerus Corporation had its IPO on 1997-01-31 under the ticker symbol CERS.
The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Cerus Corporation has a staff strength of 0 employees.
Stock update
Shares of Cerus Corporation opened at $3.67 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $3.49 - $3.71, and closed at $3.49.
This is a -5.42% slip from the previous day's closing price.
A total volume of 2,069,980 shares were traded at the close of the day’s session.
In the last one week, shares of Cerus Corporation have slipped by -12.75%.
Cerus Corporation's Key Ratios
Cerus Corporation has a market cap of $0.618 billion, indicating a price to book ratio of 8.6 and a price to sales ratio of 4.002.
In the last 12-months Cerus Corporation’s revenue was $0.154 billion with a gross profit of $0.067 billion and an EBITDA of $-0.032 billion. The EBITDA ratio measures Cerus Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cerus Corporation’s operating margin was -22.5% while its return on assets stood at -9.89% with a return of equity of -52.5%.
In Q2, Cerus Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 30.2%.
Cerus Corporation’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.287 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cerus Corporation’s profitability.
Cerus Corporation stock is trading at a EV to sales ratio of 3.46 and a EV to EBITDA ratio of -18.94. Its price to sales ratio in the trailing 12-months stood at 4.002.
Cerus Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Cerus Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Cerus Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Cerus Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Cerus Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Cerus Corporation paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $3.49
- 52-Week High
- $8.06
- 52-Week Low
- $3.27
- Analyst Target Price
- $9.1
Cerus Corporation stock is currently trading at $3.49 per share. It touched a 52-week high of $8.06 and a 52-week low of $8.06. Analysts tracking the stock have a 12-month average target price of $9.1.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Cerus Corporation
Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)
Most Active
Top Gainers
Top Losers
About
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.